| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/2008 | WO2008037931A1 Use of compounds of the avermectin family for the treatment of dermatological disorders |
| 04/03/2008 | WO2008037923A1 New derivatives of 5-thioxilopyranose |
| 04/03/2008 | WO2008037922A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 04/03/2008 | WO2008037888A2 Tetracyclic compounds, process for the preparation thereof pharmaceutical compositions comprising the same and use thereof as dopaminergic receptor ligands |
| 04/03/2008 | WO2008037881A2 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 04/03/2008 | WO2008037880A1 New class of terpene-derived compounds having an antibiotic activity, compositions containing the same ans uses thereof |
| 04/03/2008 | WO2008037827A1 Use of particular antibacterial compounds, which are derived from alliaceae, as natural additives in animal feed |
| 04/03/2008 | WO2008037809A1 Transmucosal administration of fibrate compounds and delivery system therefor |
| 04/03/2008 | WO2008037807A1 Pharmaceutical formulation comprising metformin and repaglinide |
| 04/03/2008 | WO2008037784A1 Quinolinone derivatives |
| 04/03/2008 | WO2008037783A1 Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles |
| 04/03/2008 | WO2008037746A1 Pyridooxazepine progesteron receptor modulators |
| 04/03/2008 | WO2008037716A2 Pharmaceutical compositions comprising nilotinib or its salt |
| 04/03/2008 | WO2008037681A1 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc. |
| 04/03/2008 | WO2008037628A1 Sulfonamide derivatives |
| 04/03/2008 | WO2008037626A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | WO2008037557A2 Rapidly solubilising formulation of non-steroidal anti-inflammatory drugs |
| 04/03/2008 | WO2008037555A1 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof |
| 04/03/2008 | WO2008037538A2 Modified alkoxyglycerols |
| 04/03/2008 | WO2008037502A2 Olanzapine pharmaceutical composition with anhydrous lactose |
| 04/03/2008 | WO2008037484A2 Formulations comprising cyclic compounds |
| 04/03/2008 | WO2008037482A1 Biofilm-inhibiting effect and anti-infective activity of n,c-linked arylisoquinolines and the use thereof |
| 04/03/2008 | WO2008037476A1 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
| 04/03/2008 | WO2008037459A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | WO2008037421A2 Pharmaceutical compositions comprising an s1p modulator |
| 04/03/2008 | WO2008037415A1 Use of theanine for producing a drug for use in the prophylaxis and treatment of psychiatric disorders of the central nervous system, especially of depressions and pains |
| 04/03/2008 | WO2008037381A1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 04/03/2008 | WO2008037266A1 Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases |
| 04/03/2008 | WO2008037258A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 04/03/2008 | WO2008037226A2 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 04/03/2008 | WO2008037182A1 Use of ginsenoside rg1 for treatment of cerebral ischemia and/or diseases or symptoms induced by cerebral ischemia |
| 04/03/2008 | WO2008037176A1 Transdermal preparations comprising artemisinin and/or its derivatives |
| 04/03/2008 | WO2008037171A1 A process for preparing a hyaluronic acid gel in the two crosslinking stages |
| 04/03/2008 | WO2008037074A1 Antimicrobial agents derived from crea |
| 04/03/2008 | WO2008037072A1 Cathepsin b inhibitors |
| 04/03/2008 | WO2008037047A1 Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance |
| 04/03/2008 | WO2008037045A2 Composition containing a mixture of antidepressants for treating premature ejaculation. |
| 04/03/2008 | WO2008037044A1 Oxcarbazepine-containing oral formulation and a process to obtain the same |
| 04/03/2008 | WO2008037037A2 Anti-asthmatic medicine comprising i. a. caffeine, ergotamine, zinc, papaverine, atropine, aminophyyline, glaucine etc. |
| 04/03/2008 | WO2008037011A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 04/03/2008 | WO2008022199A3 Apparatus and process for manufacturing food products with omega-3 polyunsaturated fatty acids |
| 04/03/2008 | WO2008021545A3 Modulators of muscarinic receptors |
| 04/03/2008 | WO2008021338A3 Tricyclic oxazolidone derivatives useful as pr modulators |
| 04/03/2008 | WO2008019363A3 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 04/03/2008 | WO2008018783A3 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 04/03/2008 | WO2008017883A3 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 04/03/2008 | WO2008017827A3 Azole and thiazole derivatives and their uses |
| 04/03/2008 | WO2008017721A3 Method of covering self-assembled metal or inorganic monolayer surfaces of gem-bisphosphonic compounds and uses thereof |
| 04/03/2008 | WO2008017451A3 Intermittent treatment with bone anti-resorptive compounds |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008015563A3 Salts of rosuvastatin and processes for their preparation |
| 04/03/2008 | WO2008015220A8 Granule and orally disintegrating tablet comprising oxycodone |
| 04/03/2008 | WO2008015007A3 Use of escin |
| 04/03/2008 | WO2008015005A3 Polymorphic forms of ziprasidone sulfates |
| 04/03/2008 | WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/03/2008 | WO2008013925A3 Fungicidal azocyclic amides |
| 04/03/2008 | WO2008013807A3 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/03/2008 | WO2008012622A3 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 04/03/2008 | WO2008010985A3 Phosphorus derivatives as histone deacetylase inhibitors |
| 04/03/2008 | WO2008008776A3 Hepatitis c virus inhibitors |
| 04/03/2008 | WO2008006226A8 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 04/03/2008 | WO2008004190A3 Polymorphic form of duloxetine hydrochloride |
| 04/03/2008 | WO2008004013A3 Medicament for the enhancement of cognitive function and neuroprotection |
| 04/03/2008 | WO2008002924A3 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 04/03/2008 | WO2008001204A3 Transdermal compositions of pramipexole having enhanced permeation properties |
| 04/03/2008 | WO2008000731A3 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 04/03/2008 | WO2007146983A3 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
| 04/03/2008 | WO2007146796A3 Antiproliferative compounds, compositions and methods of use |
| 04/03/2008 | WO2007146375A3 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer |
| 04/03/2008 | WO2007146284A3 Thienopyrimidines useful as modulators of ion channels |
| 04/03/2008 | WO2007145834A3 Benzamide derivatives and uses related thereto |
| 04/03/2008 | WO2007143587A8 Drug administration methods |
| 04/03/2008 | WO2007140263A9 Macrophage migration inhibitory factor antagonists and methods of using same |
| 04/03/2008 | WO2007140191A3 Glucose transport inhibitors and methods of use |
| 04/03/2008 | WO2007139860A3 Heterobicylic metalloprotease inhibitors |
| 04/03/2008 | WO2007139856A3 Heterobicyclic metalloprotease inhibitors |
| 04/03/2008 | WO2007139413A3 Polymorphs of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride |
| 04/03/2008 | WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 04/03/2008 | WO2007135131A9 Substituted pyrazinone derivatives for use as a medicine |
| 04/03/2008 | WO2007131973A3 Compositions and methods for modulating the immune system |
| 04/03/2008 | WO2007131767A3 Novel actives against prostate carcinoma |
| 04/03/2008 | WO2007131070A3 Compositions, dosage forms and methods of treating emesis |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | WO2007128674A3 Muscarinic agonists to treat impulse control disorders |
| 04/03/2008 | WO2007126898A8 Use of ladostigil for the treatment of schizophrenia |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007119028A3 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 04/03/2008 | WO2007117704A3 Pure isomers of tritoqualine |
| 04/03/2008 | WO2007115973A3 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet |
| 04/03/2008 | WO2007115198A3 Compliant electrical stimulation leads and methods of fabrication |
| 04/03/2008 | WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions |
| 04/03/2008 | WO2007109288A3 Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 04/03/2008 | WO2007107878A3 Solid dosage forms of hypnotic agent |
| 04/03/2008 | WO2007102446A3 Method and composition for treating chronic obstructive pulmonary disease |
| 04/03/2008 | WO2007101235A3 Improved antitumoral treatments |
| 04/03/2008 | WO2007100789A3 Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/03/2008 | WO2007100562A3 Use of dha and ara in the preparation of a composition for reducing triglyceride levels |
| 04/03/2008 | WO2007098189A3 New crystal forms and pharmaceutical compositions of (+) -r-zileuton |
| 04/03/2008 | WO2007087452A3 Abuse resistant and extended release formulations and method of use thereof |
| 04/03/2008 | WO2007086079B1 Sustained release dosage form of phenothiazine derivatives containing channelizer |